Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
Revolutionizing Addiction Medicine: The Role of Artificial Intelligence
Introduction Addiction medicine is becoming more of an issue as addiction-related problems continue to plague people all over the globe, resulting in serious health consequences. Addiction has become increasingly prevalent in recent years...
Exploring the Potential and Challenges of Digital and AI-Driven Psychotherapy for ADHD, OCD, Schizophrenia, and Substance Use Disorders: A Comprehensive Narrative Review
Purpose of the Review: Psychotherapy remains a fundamental component of mental health treatment, yet it encounters significant barriers to accessibility and efficacy. The integration of digital therapies, encompassing e-Health, m-Health...
Digital interventions targeting excessive substance use and substance use disorders: a comprehensive and systematic scoping review and bibliometric analysis
Addictive substances are prevalent world-wide, and their use presents a substantial and persistent public health problem. A wide range of digital interventions to decrease use and negative consequences thereof have been explored, differing...
A systematic review of chatbot-assisted interventions for substance use
Objectives: This study systematically reviewed research on the utilization of chatbot-related technologies for the prevention, assessment, and treatment of various substance uses, including alcohol, nicotine, and other drugs. Methods...
Clinical implementation of AI-based screening for risk for opioid use disorder in hospitalized adults
The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...
إدارة خدمات علاج اضطرابات استخدام المخدرات وفقًا للمعايير الدولية الأساسية للجودة
يهدف دليل إدارة خدمات علاج اضطرابات استخدام المخدرات وفقًا للمعايير الدولية الأساسية للجودة إلى مساعدة القادة والمديرين على ترجمة المعرفة الحالية وأفضل الممارسات الأخلاقية والفعّالة في مجال العلاج إلى تطبيق عملي. كما يساعد المديرين على...
Child and youth mental health in the WHO European Region: Status and actions to strengthen quality of care
For the first time WHO Regional Office for Europe brings together all of data available at the Regional level on child and youth mental health. One in seven children and adolescents aged 0–19 years old lives with a mental health condition...
Care without conditions — housing-first and employment-first approaches
Background: Across Europe, people who use drugs face persistent barriers to housing, decent work, healthcare and safety. All too often, ‘reintegration’ tends to be tied largely to abstinence, at the risk of excluding those who are not ready, or do not wish, to stop using psychoactive substances.
Day 1, 14:00 - 15:30, Plenary 3: Establishing Global-Regional Collaboration in Prevention, Treatment and Recovery Programs
Panel Presented at Indonesia 2025 on the 17th of September 2025 Moderator: Goodman Sibeko Presentations: Ma Veronica Felipe: International Consortium of Universities for Drug Demand Reduction Joanna Travis-Roberts: Global Opportunities for...
Mental Health Policy in the Management of Drug Abuse Disorders
The issue of drug (NAPZA) abuse at the global, regional, and national levels remains a serious public health issue, with widespread impacts on social, economic, and security domains. Based on the 2023 National Survey on Drug Abuse conducted by BNN, BRIN, and BPS, the prevalence rate of drug abuse in Indonesia among individuals aged 15–64 years was1.73%, equivalent to approximately 3.33 million people. Furthermore, the prevalence rate of drug use was 2.20%, or approximately 4.24 million people.